Cure8 research brief
If you or a child had Kawasaki disease, this study suggests there may be a higher long-term chance of certain skin autoimmune conditions (psoriasis, vitiligo) but no clear increase in IBD or several other autoimmune diseases over 20 years. That can guide long-term surveillance and discussions with clinicians.
Pediatric patients with prior Kawasaki disease; parents and caregivers; pediatricians; dermatologists; researchers of pediatric immune disorders.
The study suggests selective long-term immune dysregulation after KD, most clearly affecting skin autoimmune conditions. These findings come from a large insurer database with long follow-up but rely on diagnostic codes and small event counts for rare cancers, which limits certainty.
Findings are from a retrospective electronic health record cohort and rely on diagnostic coding. The Hodgkin lymphoma signal is exploratory with very few events; interpretations should be cautious. The summary is based on the article abstract provided.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declarations. Ethics approval and consent to participate: The study protocol was reviewed and approved by the Institutional Review Board (Helsinki Committee) of Carmel Medical Center, Clalit Health Services (approval number: CMC-0070–24). Individual informed consent was waived by the Committee because the study used de-identified retrospective data from the central Clalit data warehouse, in accordance with national regulations governing the secondary use of routinely collected health data. All procedures were conducted in compliance with the Declaration of Helsinki and Israeli Ministry of Health data-protection standards. Conflicts of interest: The authors declare no competing interests.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study highlights changing patterns of IBD presentation and treatment over 26 years in a large Hispanic cohort, which may affect outcomes and access-to-care discussions for Hispanic patients.
This study suggests that using 5‑ASA drugs early in children with Crohn’s disease was common but linked to more steroid use, delayed biologic treatment, and lower biologic durability — outcomes that matter for long‑term...
A simple blood ratio measured before surgery (LCR) may help predict which children with UC are at higher risk of surgical site infection after IPAA, potentially guiding preoperative care.
